40
Want to stay up-to-date on the science and politics driving biotechnology today? sign up Receive the Biotechnology Newsletter in your inbox.
Good morning, ladies and gentlemen. Here, Damien talks about the accomplishments of pharma CEOs, further biotech layoffs, and relief from the GLP-1 panic.
How will we remember Humira?
For the past decade, AbbVie CEO Richard Gonzalez has presided over one of the pharmaceutical industry’s most enviable cash cows, making billions even though the core patent for the autoimmune drug Humira has expired. We have increased sales by US$. Now that Gonzalez is set to step down, what will the industry remember: lucrative profits or constant controversy?
